Christopher Mirabelli Leap Therapeutics, Inc. (LPTX) insider trading activity

LPTX Quotes by TradingView

Christopher Mirabelli is Director of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 5,086 shares of LPTX, which is worth approximately $19,021. The most recent transaction as insider was on Jan 26, 2024, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.09K
0% 3M change
n/a 12M change
Total Value Held $19,021

Christopher Mirabelli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 49.57%
5,086 Common Stock
CM

Christopher Mirabelli

Director
Cambridge, MA

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPTX